Dr. George Sledge (IMAGE)
Caption
“By integrating imaging, clinical data, and molecular profiling, we are advancing beyond single-dimension diagnostics to deliver a more precise and comprehensive understanding of recurrence risk in breast cancer,” said Caris EVP and Chief Medical Officer George W. Sledge, Jr., MD. “The development of these models underscores the transformative power of multimodal AI and machine learning in precision oncology.”
Credit
Caris Life Sciences
Usage Restrictions
No restrictions.
License
Public Domain